Related Experiment Videos
Multifocal atrial tachycardia and Ibutilide.
1Division of Cardiology, The Brooklyn Hospital Center, New York Presbyterian Hospital Network, Brooklyn, NY 11201, USA.
The American Journal of Geriatric Cardiology
|July 17, 2001
Summary
Multifocal atrial tachycardia, a heart rhythm issue common in older adults, can cause serious hemodynamic problems. This case study shows successful treatment using Ibutilide, a Class III antiarrhythmic drug.
Area of Science:
- Cardiology
- Electrophysiology
- Geriatric Medicine
Background:
- Multifocal atrial tachycardia (MAT) is an irregular heart rhythm predominantly observed in elderly patients.
- Understanding the hemodynamic impact of MAT in this demographic is crucial for effective management.
- The underlying mechanisms of MAT, particularly triggered activity, are areas of ongoing research.
Observation:
- A case of multifocal atrial tachycardia in an elderly woman presented with significant hemodynamic compromise.
- The patient's clinical presentation highlighted the potential severity of MAT in older individuals.
- Continuous electrocardiographic monitoring was essential for diagnosing and managing the arrhythmia.
Findings:
- Successful management of multifocal atrial tachycardia was achieved using Ibutilide, a Class III antiarrhythmic agent.
- The treatment's efficacy suggests a potential alternative to conventional therapies for MAT.
- This case challenges the widely accepted theory of triggered activity as the sole mechanism for MAT.
Implications:
- Ibutilide may represent a viable therapeutic option for elderly patients experiencing multifocal atrial tachycardia.
- Further research is warranted to explore the mechanisms of MAT and the role of Class III antiarrhythmics.
- This case contributes to the understanding of managing complex arrhythmias in geriatric cardiology.